The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II safety and preliminary efficacy of PM1022, a bispecific antibody targeting PD-L1 and TIGIT, in patients with advanced solid tumors.
 
Junli Xue
No Relationships to Disclose
 
Yan Zhang
No Relationships to Disclose
 
Xudong Hu
No Relationships to Disclose
 
Wei Zhao
No Relationships to Disclose
 
Yuping Sun
Honoraria - AstraZeneca; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Roche
Research Funding - Pfizer; Roche
 
Qun Li
No Relationships to Disclose
 
Xiaoying Jin
No Relationships to Disclose
 
Liqiong Xue
No Relationships to Disclose
 
Xiaoxiao Ge
No Relationships to Disclose
 
Fengjuan Lin
No Relationships to Disclose
 
Wenbo Tang
No Relationships to Disclose
 
Jiuli Zhou
No Relationships to Disclose
 
Ye Guo
Honoraria - BeiGene; Merck Serono; MSD; Roche
Consulting or Advisory Role - GlaxoSmithKline; Merck Serono; MSD; Roche